Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and estrogen β receptor polymorphisms with clinical outcomes-Reference-Cited by-同舟云学术

Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and estrogen β receptor polymorphisms with clinical outcomes

Published:2023-06-16 Issue:3 Volume:81 Page:621-630
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Pallotti Francesco^ORCID,Senofonte Giulia^ORCID,Conflitti Anna Chiara^ORCID,Giancotti Antonella^ORCID,Anzuini Antonella,Delli Paoli Enrico^ORCID,Di Chiano Silvia^ORCID,Faja Fabiana^ORCID,Gatta Valentina^ORCID,Mondo Alessandro^ORCID,Mosconi Maddalena,Rizzo Flavio^ORCID,Spiniello Lorenzo^ORCID,Lombardo Francesco^ORCID,Paoli Donatella^ORCID

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-023-03421-8.pdf

Reference52 articles.

1. A.D. Fisher, G. Senofonte, C. Cocchetti, G. Guercio, V. Lingiardi, M.C. Meriggiola, M. Mosconi, G. Motta, J. Ristori, A.M. Speranza et al. SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. J. Endocrinol. Invest. 45, 657–673 (2022). https://doi.org/10.1007/s40618-021-01694-2

2. W.C. Hembree, P.T. Cohen-Kettenis, L. Gooren, S.E. Hannema, W.J. Meyer, M.H. Murad, S.M. Rosenthal, J.D. Safer, V. Tangpricha, G.G. T’Sjoen, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 102, 3869–3903 (2017). https://doi.org/10.1210/jc.2017-01658

3. F. Pallotti, G. Senofonte, F, Konstantinidou, S. Di Chiano, F. Faja, F. Rizzo, F. Cargnelutti, C. Krausz, D. Paoli, A. Lenzi et al. Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter’s Methylation in AFAB People. Biomedicines 10 (2022) https://doi.org/10.3390/biomedicines10020459

4. M. Zitzmann, Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat. Clin. Pract. Urol. 4, 161–166 (2007). https://doi.org/10.1038/ncpuro0706

5. L. Westberg, F. Baghaei, R. Rosmond, M. Hellstrand, M. Landén, M. Jansson, G. Holm, P. Björntorp, E. Eriksson, Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J. Clin. Endocrinol. Metab. 86, 2562–2568 (2001). https://doi.org/10.1210/jcem.86.6.7614

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth;Endocrine;2023-12-23